📰 Action Indicated News
Page 2 - Action Indicated News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Action Indicated. Real-time updates on events, politics, business and more.
December 18, 2023
NORTHAMPTON, MA / ACCESSWIRE / December 18, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportEthics and ComplianceIntegrity is a core Alkermes value and the foundation of the way we do business. Alkermes is dedicated to upholding legal, regulatory and ethical standards in...
November 20, 2023
Stocks to watch out for today: SBI Cards, NBCC, Cipla, Dabur, Macrotech Developers and more
November 19, 2023
Momentum indicators suggest that the Nifty will consolidate in the near term. The Nifty will have to hold the crucial support of 19,600-19,450. If it manages to go past 19,850 decisively, it can even cross the 20,000 mark, experts say
July 27, 2023
The factory that fills the self-injection pens for booming weight-loss drug Wegovy has repeatedly breached U.S. sterile-safety rules in recent years and staff have failed to perform required quality...
July 27, 2023
The factory responsible for filling the self-injection pens of the booming weight-loss drug Wegovy, Catalent, has been found to repeatedly breach US sterile-safety rules in recent years, according to a Reuters review of regulatory documents. Inspectors from the US Food and Drug Administration (FDA) visited the Catalent plant in Brussels in October 2021 and August…
June 15, 2023
Bliss GVS Pharma Ltd has now received the EIR indicating closure of the inspection through which the US FDA agency assigned the inspection classification of the facility as Voluntary Action Indicated.
May 30, 2023
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
April 24, 2023
Sun Pharma stock has gained 5.88 per cent in a year and fallen 2.29 percent in 2023. A total of 0.52 lakh shares of the firm changed hands amounting to a turnover of Rs 5.08 crore on BSE.
April 23, 2023
"US FDA has directed the Company to take certain corrective actions at the Mohali facility before releasing further final product batches into the US," the company said.
March 8, 2023
The USFDA has assigned the inspection classification of the API facility as Voluntary Action Indicated pursuant to its inspection at the API manufacturing facility of Jubilant Pharmova Ltd at Nanjangud during 05-13 December 2022.